Publicaciones en colaboración con investigadores/as de Centro Nacional de Epidemiología (28)

2021

  1. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

2020

  1. Effects of Motor Symptom Laterality on Clinical Manifestations and Quality of Life in Parkinson's Disease

    Journal of Parkinson's Disease, Vol. 10, Núm. 4, pp. 1611-1620

  2. Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

    Scientific Reports, Vol. 10, Núm. 1

  3. The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype

    Neurological Sciences, Vol. 41, Núm. 10, pp. 2883-2892

2019

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

    European Journal of Neurology, Vol. 26, Núm. 11, pp. 1399-1407

  2. High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson’s disease patients

    Journal of Neural Transmission, Vol. 126, Núm. 12, pp. 1599-1608

  3. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

    Parkinsonism and Related Disorders, Vol. 66, pp. 151-157

  4. Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer

    Movement Disorders, Vol. 34, Núm. 10, pp. 1488-1495

  5. The Parkinson's Disease Sleep Scale–2 (PDSS-2): Validation of the Spanish Version and Its Relationship With a Roommate-Based Version

    Movement Disorders Clinical Practice, Vol. 6, Núm. 4, pp. 294-301

2018

  1. Minimal Clinically Important Difference for UPDRS-III in Daily Practice

    Movement Disorders Clinical Practice

  2. Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients

    Parkinsonism and Related Disorders, Vol. 52, pp. 83-89

2017

  1. Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration

    Movement Disorders Clinical Practice, Vol. 4, Núm. 4, pp. 536-544

  2. Self-Assessment of Disability in Parkinson's Disease: The MDS-UPDRS Part II Versus Clinician-Based Ratings

    Movement Disorders Clinical Practice, Vol. 4, Núm. 4, pp. 529-535

2016

  1. Analysis of four scales for global severity evaluation in Parkinson’s disease

    npj Parkinson's Disease, Vol. 2, Núm. 1

  2. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

  3. Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population

    Parkinsonism and Related Disorders, Vol. 25, pp. 52-57

2015

  1. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale

    European Journal of Neurology, Vol. 22, Núm. 1, pp. 37-43

  2. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale

    Parkinsonism and Related Disorders, Vol. 21, Núm. 1, pp. 50-54

2014

  1. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients

    European Journal of Neurology, Vol. 21, Núm. 3, pp. 519-524

2013

  1. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

    Journal of Neurology, Vol. 260, Núm. 1, pp. 228-236